eIF6 as a Promising Diagnostic and Prognostic Biomarker for Poorer Survival of Cutaneous Melanoma

BACKGROUND: Skin cutaneous melanoma (SKCM) is the deadliest skin cancer and has the most rapidly increasing incidences among all cancer types. Previous research elucidated that melanoma can only be successfully treated with surgical abscission in the early stage. Therefore, reliable and specific bio...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Fangyingnan, Waheed, Saquib, Armato, Ubaldo, Wu, Jun, Zhang, Chao, Li, Zhibin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189357/
https://www.ncbi.nlm.nih.gov/pubmed/35707354
http://dx.doi.org/10.3389/fonc.2022.848346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189357/
https://www.ncbi.nlm.nih.gov/pubmed/35707354
http://dx.doi.org/10.3389/fonc.2022.848346

Ejemplares similares